Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH (RxEACH)

This study has been completed.
Alberta Health & Wellness
Alberta Health Services
Merck Frosst Canada Ltd.
Information provided by (Responsible Party):
Ross T. Tsuyuki, University of Alberta Identifier:
First received: November 1, 2013
Last updated: September 14, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)